.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
Covington
Fuji
Julphar
Citi
Cerilliant
Chubb
Colorcon
Cantor Fitzgerald

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078809

« Back to Dashboard
NDA 078809 describes TECHNETIUM TC 99M SESTAMIBI, which is a drug marketed by Jubilant Draximage, Cardinal Health 414, and Pharmalucence, and is included in three NDAs. It is available from three suppliers. Additional details are available on the TECHNETIUM TC 99M SESTAMIBI profile page.

The generic ingredient in TECHNETIUM TC 99M SESTAMIBI is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.

Summary for NDA: 078809

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 078809

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 078809

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TECHNETIUM TC 99M SESTAMIBI
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION 078809 ANDA Cardinal Health 414, LLC 65857-500 65857-500-05 5 VIAL in 1 CARTON (65857-500-05) > 5 mL in 1 VIAL
TECHNETIUM TC 99M SESTAMIBI
technetium tc-99m sestamibi kit
INJECTABLE;INJECTION 078809 ANDA Cardinal Health 414, LLC 65857-500 65857-500-20 20 VIAL in 1 CARTON (65857-500-20) > 5 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Apr 28, 2009TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cerilliant
Medtronic
Harvard Business School
Covington
Johnson and Johnson
Express Scripts
UBS
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot